Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 7/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | HTT | P42858 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MTOR | P42345 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.43 |
| ▸ | MITF | O75030 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12720859 | 0.92 | AGTR1 (0.45) | CTSAMAPTSMN1; SMN2HTTRAB9A | |
| SCHEMBL12720836 | 0.80 | NPC1 (0.59) | CTSAMAPTSMN1; SMN2HTTRAB9A | |
| SCHEMBL12720832 | 0.77 | NPC1 (0.57) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL12720868 | 0.73 | USP30 (0.48) | CTSAMAPTSMN1; SMN2HTTRAB9A | |
| SCHEMBL18135106 | 0.72 | CTSA (0.56) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL14875861 | 0.71 | CTSA (0.54) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL1053757 | 0.70 | CTSA (0.56) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL18135115 | 0.70 | CTSA (0.48) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL10098367 | 0.69 | KMO (0.57) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL14882802 | 0.69 | CTSA (0.47) | CTSAMAPTSMN1; SMN2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7928049-B2 | Use of metal complex compounds as oxidation catalysts | BASF SE Ludwigshafen (DE) | 2011-04-19 | — | — | US | disclosed |
| US-7928049-B2 | Use of metal complex compounds as oxidation catalysts | BASF SE Ludwigshafen (DE) | 2011-04-19 | — | — | US | disclosed |
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA CORPORATION (US) | 2011-01-27 | — | — | US | disclosed |
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA CORPORATION (US) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | SOD1, MPO, LPO | CTSA 1281/4885MAPT 1746/4885SMN1; SMN2 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.